Anticardiolipin antibodies in acute myeloid leukemia: Prevalence and clinical significance
- 1 February 1998
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 57 (2) , 139-143
- https://doi.org/10.1002/(sici)1096-8652(199802)57:2<139::aid-ajh8>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Anticardiolipin and Anti-β2-GPI Are Two Distinct Populations of AutoantibodiesThrombosis and Haemostasis, 1996
- Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancyBritish Journal of Cancer, 1995
- Cerebral Infarction in a Girl who Developed Anticardiolipin Syndrome After Acute Lymphoblastic LeukemiaPediatric Hematology and Oncology, 1992
- Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patientsAmerican Journal of Hematology, 1991
- Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy populationAustralian and New Zealand Journal of Medicine, 1990
- Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE DisordersAnnals of Internal Medicine, 1990
- ANTIPHOSPHOLIPID ANTIBODIESBritish Journal of Haematology, 1990
- Study of three patients with monoclonal gammopathies and ‘lupus‐like’ anticoagulantsBritish Journal of Haematology, 1989
- Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.Annals of the Rheumatic Diseases, 1988
- LUPUS‐TYPE COAGULATION INHIBITOR IN HAIRY CELL LEUKAEMIA AND REOSOLUTION WITH SPLENECTOMYBritish Journal of Haematology, 1987